169 related articles for article (PubMed ID: 19765766)
1. Restoring barrier function to acid damaged bladder by intravesical chondroitin sulfate.
Hauser PJ; Buethe DA; Califano J; Sofinowski TM; Culkin DJ; Hurst RE
J Urol; 2009 Nov; 182(5):2477-82. PubMed ID: 19765766
[TBL] [Abstract][Full Text] [Related]
2. Intravesical chondroitin sulfate inhibits recruitment of inflammatory cells in an acute acid damage "leaky bladder" model of cystitis.
Engles CD; Hauser PJ; Abdullah SN; Culkin DJ; Hurst RE
Urology; 2012 Feb; 79(2):483.e13-7. PubMed ID: 22137543
[TBL] [Abstract][Full Text] [Related]
3. In the absence of overt urothelial damage, chondroitinase ABC digestion of the GAG layer increases bladder permeability in ovariectomized female rats.
Hurst RE; Van Gordon S; Tyler K; Kropp B; Towner R; Lin H; Marentette JO; McHowat J; Mohammedi E; Greenwood-Van Meerveld B
Am J Physiol Renal Physiol; 2016 May; 310(10):F1074-80. PubMed ID: 26911855
[TBL] [Abstract][Full Text] [Related]
4. Exogenous glycosaminoglycans coat damaged bladder surfaces in experimentally damaged mouse bladder.
Kyker KD; Coffman J; Hurst RE
BMC Urol; 2005 Mar; 5():4. PubMed ID: 15788101
[TBL] [Abstract][Full Text] [Related]
5. Restoring the barrier of chronically damaged urothelium using chondroitin sulfate glycosaminoglycan-replenishment therapy.
Rozenberg BB; van Ginkel CJ; Janssen DAW
Curr Opin Urol; 2024 Mar; 34(2):44-51. PubMed ID: 37962190
[TBL] [Abstract][Full Text] [Related]
6. Improving the barrier function of damaged cultured urothelium using chondroitin sulfate.
Rozenberg BB; Janssen DAW; Jansen CFJ; Schalken JA; Heesakkers JPFA
Neurourol Urodyn; 2020 Feb; 39(2):558-564. PubMed ID: 31774209
[TBL] [Abstract][Full Text] [Related]
7. The distribution and function of chondroitin sulfate and other sulfated glycosaminoglycans in the human bladder and their contribution to the protective bladder barrier.
Janssen DA; van Wijk XM; Jansen KC; van Kuppevelt TH; Heesakkers JP; Schalken JA
J Urol; 2013 Jan; 189(1):336-42. PubMed ID: 23174248
[TBL] [Abstract][Full Text] [Related]
8. Intravesical hyaluronic acid and chondroitin sulfate alone and in combination for urinary tract infection: assessment of protective effects in a rat model.
Tasdemir S; Tasdemir C; Vardi N; Yakupogullari Y; Duman Y; Parlakpinar H; Sagir M; Acet A
Int J Urol; 2012 Dec; 19(12):1108-12. PubMed ID: 22852837
[TBL] [Abstract][Full Text] [Related]
9. SuperGAG biopolymers for treatment of excessive bladder permeability.
Towner RA; Greenwood-Van Meerveld B; Mohammadi E; Saunders D; Smith N; Sant GR; Shain HC; Jozefiak TH; Hurst RE
Pharmacol Res Perspect; 2021 Feb; 9(1):e00709. PubMed ID: 33540486
[TBL] [Abstract][Full Text] [Related]
10. Intravesical application of rebamipide promotes urothelial healing in a rat cystitis model.
Funahashi Y; Yoshida M; Yamamoto T; Majima T; Takai S; Gotoh M
J Urol; 2014 Dec; 192(6):1864-70. PubMed ID: 24992331
[TBL] [Abstract][Full Text] [Related]
11. Abnormal expression of molecular markers for bladder impermeability and differentiation in the urothelium of patients with interstitial cystitis.
Slobodov G; Feloney M; Gran C; Kyker KD; Hurst RE; Culkin DJ
J Urol; 2004 Apr; 171(4):1554-8. PubMed ID: 15017219
[TBL] [Abstract][Full Text] [Related]
12. Elucidating Mechanisms of Bladder Repair after Hyaluronan Instillation in Ketamine-Induced Ulcerative Cystitis in Animal Model.
Lee YL; Lin KL; Chuang SM; Lee YC; Lu MC; Wu BN; Wu WJ; Yuan SF; Ho WT; Juan YS
Am J Pathol; 2017 Sep; 187(9):1945-1959. PubMed ID: 28826558
[TBL] [Abstract][Full Text] [Related]
13. Toxic factors in human urine that injure urothelium.
Rajasekaran M; Stein P; Parsons CL
Int J Urol; 2006 Apr; 13(4):409-14. PubMed ID: 16734860
[TBL] [Abstract][Full Text] [Related]
14. New preclinical data - the case for Ialuril®.
Salonia A
Urologia; 2016 Jun; 83 Suppl 1():15-9. PubMed ID: 27405345
[TBL] [Abstract][Full Text] [Related]
15. Intravesical drug delivery: Challenges, current status, opportunities and novel strategies.
GuhaSarkar S; Banerjee R
J Control Release; 2010 Dec; 148(2):147-59. PubMed ID: 20831887
[TBL] [Abstract][Full Text] [Related]
16. A randomized, open-label, multicenter study of the efficacy and safety of intravesical hyaluronic acid and chondroitin sulfate versus dimethyl sulfoxide in women with bladder pain syndrome/interstitial cystitis.
Cervigni M; Sommariva M; Tenaglia R; Porru D; Ostardo E; Giammò A; Trevisan S; Frangione V; Ciani O; Tarricone R; Pappagallo GL
Neurourol Urodyn; 2017 Apr; 36(4):1178-1186. PubMed ID: 27654012
[TBL] [Abstract][Full Text] [Related]
17. Pannexin 1 channels mediate the release of ATP into the lumen of the rat urinary bladder.
Beckel JM; Daugherty SL; Tyagi P; Wolf-Johnston AS; Birder LA; Mitchell CH; de Groat WC
J Physiol; 2015 Apr; 593(8):1857-71. PubMed ID: 25630792
[TBL] [Abstract][Full Text] [Related]
18. Preclinical Animal Studies of Intravesical Recombinant Human Proteoglycan 4 as a Novel Potential Therapy for Diseases Resulting From Increased Bladder Permeability.
Greenwood-Van Meerveld B; Mohammadi E; Latorre R; Truitt ER; Jay GD; Sullivan BD; Schmidt TA; Smith N; Saunders D; Ziegler J; Lerner M; Hurst R; Towner RA
Urology; 2018 Jun; 116():230.e1-230.e7. PubMed ID: 29545038
[TBL] [Abstract][Full Text] [Related]
19. Abnormalities in Expression of Structural, Barrier and Differentiation Related Proteins, and Chondroitin Sulfate in Feline and Human Interstitial Cystitis.
Hauser PJ; VanGordon SB; Seavey J; Sofinowski TM; Ramadan M; Abdullah S; Buffington CA; Hurst RE
J Urol; 2015 Aug; 194(2):571-7. PubMed ID: 25636658
[TBL] [Abstract][Full Text] [Related]
20. A system for the enhancement of adenovirus mediated gene transfer to uro-epithelium.
Lin LF; Zhu G; Yoo JJ; Soker S; Sukhatme VP; Atala A
J Urol; 2002 Aug; 168(2):813-8. PubMed ID: 12131373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
